Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs
| Autor: | Clément, Valérie, Raimond, Véronique |
|---|---|
| Zdroj: | In Value in Health February 2019 22(2):220-224 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect